Bausch Health Companies Inc (BHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -205,000 | -66,000 | -937,000 | -1,009,000 | -1,200,000 |
| Depreciation Amortization | 763,000 | 366,000 | 1,607,000 | 1,231,000 | 832,000 |
| Income taxes - deferred | -99,000 | -83,000 | -225,000 | -137,000 | -120,000 |
| Accounts receivable | 107,000 | 197,000 | -229,000 | -177,000 | -48,000 |
| Accounts payable and accrued liabilities | -26,000 | -75,000 | 121,000 | N/A | 245,000 |
| Other Working Capital | -105,000 | 16,000 | -128,000 | 89,000 | 147,000 |
| Other Operating Activity | -375,000 | -418,000 | 1,217,000 | 1,405,000 | 982,000 |
| Operating Cash Flow | $60,000 | $-63,000 | $1,426,000 | $1,402,000 | $838,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -98,000 | -46,000 | 400,000 | 478,000 | -103,000 |
| Purchase Of Investment | -14,000 | -5,000 | -19,000 | -14,000 | -11,000 |
| Sale Of Investment | 13,000 | 6,000 | 15,000 | 11,000 | 8,000 |
| Purchase Sale Intangibles | -15,000 | -11,000 | -14,000 | -9,000 | -4,000 |
| Other Investing Activity | -15,000 | -11,000 | 13,000 | 14,000 | 7,000 |
| Investing Cash Flow | $-114,000 | $-56,000 | $409,000 | $489,000 | $-99,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,320,000 | 986,000 | 2,100,000 | 1,576,000 | 1,579,000 |
| Debt Repayment | -7,083,000 | -485,000 | -3,440,000 | -3,200,000 | -2,100,000 |
| Common Stock Issued | 675,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -74,000 | -33,000 | -173,000 | -164,000 | -110,000 |
| Financing Cash Flow | $-162,000 | $468,000 | $-1,513,000 | $-1,788,000 | $-631,000 |
| Exchange Rate Effect | -24,000 | -8,000 | -19,000 | -15,000 | -6,000 |
| Beginning Cash Position | 2,119,000 | 2,119,000 | 1,816,000 | 1,816,000 | 1,816,000 |
| End Cash Position | 1,879,000 | 2,460,000 | 2,119,000 | 1,904,000 | 1,918,000 |
| Net Cash Flow | $-240,000 | $341,000 | $303,000 | $88,000 | $102,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 60,000 | -63,000 | 1,426,000 | 1,402,000 | 838,000 |
| Capital Expenditure | -98,000 | -46,000 | -269,000 | -191,000 | -128,000 |
| Free Cash Flow | -38,000 | -109,000 | 1,157,000 | 1,211,000 | 710,000 |